NDC 80425-0104

Relafen

Nabumetone 750mg

Relafen is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Advanced Rx Pharmacy Of Tennessee, Llc. The primary component is Nabumetone.

Product ID80425-0104_b4f2248a-e37f-2135-e053-2a95a90af4d9
NDC80425-0104
Product TypeHuman Prescription Drug
Proprietary NameRelafen
Generic NameNabumetone 750mg
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-06-26
Marketing CategoryANDA / ANDA
Application NumberANDA078420
Labeler NameAdvanced Rx Pharmacy of Tennessee, LLC
Substance NameNABUMETONE
Active Ingredient Strength750 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 80425-0104-1

30 TABLET in 1 BOTTLE (80425-0104-1)
Marketing Start Date2019-06-26
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Relafen" or generic name "Nabumetone 750mg"

NDCBrand NameGeneric Name
73684-100RELAFENNABUMETONE
73684-101RELAFENNABUMETONE
80425-0052RelafenNabumetone 500mg
80425-0053RelafenNabumetone 500mg
80425-0054RelafenNabumetone 500mg
80425-0104RelafenNabumetone 750mg

Trademark Results [Relafen]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RELAFEN
RELAFEN
87702292 not registered Live/Pending
Argent Development Group, LLC
2017-11-29
RELAFEN
RELAFEN
86251872 not registered Dead/Abandoned
Argent Development Group, LLC
2014-04-14
RELAFEN
RELAFEN
73353073 1248125 Dead/Cancelled
Beecham Inc.
1982-03-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.